期刊文献+

环孢素与伏立康唑联合应用引起的高血钾症 被引量:10

Hyperkalemia developed by the use of ciclosporin combination with voriconazole
原文传递
导出
摘要 在2例恶性血液病合并真菌感染患者的治疗中发现,环孢素与伏立康唑联用导致环孢素血药浓度升高,引起高血钾症。在治疗过程中应减少环孢素给药剂量并监测其血药浓度,根据监测结果及时调整剂量。 Two hematologic patients received ciclosporin for their long duration of treatments.The evaluated blood ciclosporin levels and hyperkalemia were developed when oral voriconazole was added to their regimem for treating fungal infections.The dosage of ciclosporin should be decreased when the two drugs were co-administered,and blood ciclosporin concentration should be monitered in order to ensure the safety and efficiency in patients.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2012年第2期146-147,共2页 The Chinese Journal of Clinical Pharmacology
关键词 伏立康唑 环孢素 药物相互作用 高血钾症 voriconazole ciclosporin drug-drug interaction hyperkalemia
  • 相关文献

参考文献4

  • 1刘治军,傅得兴,孙春华,张亚同.环孢素与其他药物相互作用的临床研究[J].药物不良反应杂志,2006,8(3):197-201. 被引量:8
  • 2Jeong S, Nguyen PD, Desta Z. Comprehensive in vitro analysis of vori- conazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3A [ J] . Antimicrob Agents Chernother, 2009 ;53 : 541 - 551.
  • 3Romero AJ,Pogamp PL,Nilsson LG,et al. Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients[ J]. Clin Pharmacol Ther ,2002 ;71:226 -234.
  • 4Groll AH, Kolve H, Ehlert K, et al. Pharmacokinetic interaction be- tween voriconazole and ciclosporin A following allogeneic bone mar- row transplantation [ J ] . J Antimicrob Chemother, 2004 ; 53 : 113 - 114.

二级参考文献28

  • 1卢一平,沈宏,杨宇如,唐科仕,王莉.钙通道阻滞剂在肾移植术后早期应用的临床研究[J].华西医学,1996,11(4):483-486. 被引量:4
  • 2Drachenberg CB,Klassen DK,Weir MR,et al.Islet cell damage associated with tacrolimus and cyclosporine:morphological features in pancreas allograft biopsies and clinical correlation[J],Transplantation,1999,68(3):396-402.
  • 3Slobodan Rendic.Summary of information on hman CYP enzymes:hman P450 metabolism data[J].Drug Metabolism Reviews,2002,34(1-2),83-448.
  • 4El-Husseini A,El-Basuony F,Mahmoud I,et al.Impact of the cyclosporine-ketoconazole interaction in children with steroid-dependent idiopathic nephrotic syndrome[J].Eur J Clin Pharmacol,2006,62(1):3-8.
  • 5El-Husseini A,El-Basuony F,Donia A,et al.Co-admin istration of cyclosporine and ketoconazole in children with minimal change nephrotic syndrome[J].Nephron Clin Pract,2005,100(2):27-32.
  • 6El-Husseini A,el-Basuony F,Mahmoud I,et al.Co-administration of cyclosporine and ketoconazole in idiopathic childhood nephrosis[J].Pediatr Nephrol,2004,19 (9):976-981.
  • 7El-Agroudy AE,Sobh MA,Hamdy AF,et al.A prospective,randomized study of coadministration of ketoconazole and cyclosporine a in kidney transplant recipients:ten-year follow-up[J].Transplantation,2004,77(9):1371 1371-1376.
  • 8Gerntholtz T,Pascoe MD,Botha JF,et al.The use of a cyclosporin-ketoconazol combination:making renal transplantation affordable in developing countries[J].Eur J Clin Pharmacol,2004,60(3):143-148.
  • 9Schmider J,Greenblatt DJ,VonMoltke LL,et al.Inhibi tion of cytochrome P450 by nefazodone in vitro:studies of dextromethorphan O-and N-demethylation[J].Br J Clin Pharmacol,1996,41:339-343.
  • 10Dominguez J,Kompatzki A,Foradori A,et al.Ketoconazole alters cyclosporine pharmacokinetic profile and may predispose to acute rejection[J].Transplant Proc,2003,35(7):2522-3.

共引文献7

同被引文献72

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部